Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Devonian Health Group Inc V.GSD

Alternate Symbol(s):  DVHGF

Healthcare Biotechnology
Devonian Health Group Inc. is a clinical-stage pharmaceutical company. It specializes in the development of drugs for various autoimmune inflammatory conditions with novel therapeutic approaches to targeting unmet medical needs. It is developing prescription drugs for the treatment of inflammatory autoimmune diseases, including but not limited to, ulcerative colitis and atopic dermatitis. It is also involved in the development of cosmeceutical products, leveraging the same proprietary approach employed with their pharmaceutical offerings. Its flagship product, Thykamine, is a pharmaceutical product issued from its SUPREX platform, for the prevention and treatment of health problems related to inflammation and oxidative stress, including ulcerative colitis, atopic dermatitis, psoriasis, rheumatoid arthritis, and other autoimmune diseases. Its cosmeceutical products include R-Spinasome and Purgenesis. Its subsidiary, Altius Healthcare Inc., sells prescription pharmaceutical products.


TSXV:GSD - Post by User

Devonian Health Group Inc
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(276)
•••
  • wallywagonX
Post by wallywagonon Mar 29, 2023 9:23am
272 Views
Post# 35366606

This new CEO STINKS!!!!

This new CEO STINKS!!!!Mr Pierre. 7 months in. Stock Price down 68%. Power Play on Board. Got his poeple in but has done
squat for Shareholder Value. WTF??!! He's got the backing. Needs to raise money now. The full lot
not a little at a time.   Which will mean more friggin dilution. Too much time wasted here. Has to generate buying NOW!!! Get Phase 3 going NOW. Get new shareholders so the original ones can
benefit deservedly.
Slacking and Sloppy GSD Management.  Mr Boulet did nothing for shareholders.
I am hearing alot of shareholder are unhappy and are going to pound this stock into the ground
Will take pennies. Write off as a loss and move on. TIMES UP.
<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities